Invention Grant
- Patent Title: Infective countermeasures
-
Application No.: US17804236Application Date: 2022-05-26
-
Publication No.: US12003614B2Publication Date: 2024-06-04
- Inventor: Laurent Castelnovi , Guillaume Barbu , Luk Bettale , Thomas Chabrier , Nicolas Debande , Christophe Giraud , Nathan Reboud
- Applicant: Idemia France
- Applicant Address: FR Courbevoie
- Assignee: IDEMIA FRANCE
- Current Assignee: IDEMIA FRANCE
- Current Assignee Address: FR Courbevoie
- Agency: NIXON & VANDERHYE
- Priority: FR 05447 2021.05.26
- Main IPC: G06F21/72
- IPC: G06F21/72 ; H04L9/00

Abstract:
The invention proposes a novel type of infective countermeasure against fault injection attacks. Instead of determining the injected error before amplifying it, the novel countermeasure applies the same diffusion function to two intermediate ciphers obtained by executing a cryptographic operation on an input. The error is therefore amplified within the same intermediate ciphers, referred to as infective ciphers after diffusion. It is then possible to use diffusion functions which do not map the cipher 0 as an output equal to 0. A cipher recomposed from bits of undiffused ciphers is also generated. These infective and recomposed ciphers are XOR-combined to provide an output cipher. This approach makes it possible to adapt, by simple duplication of the pairs and associated specific diffusion functions, the protection offered by the countermeasure to a desired number of injected faults.
Public/Granted literature
- US20220393852A1 INFECTIVE COUNTERMEASURES Public/Granted day:2022-12-08
Information query